Two Ireland South East tech companies are using their innovation capacity to help manage the Covid-19 crisis. Nearform are working with the HSE to develop a mobile tracing app for the disease. While Taoglas are using their IoT technology expertise to help manage crowd sizes and social distancing protocols. Read more
The project, titled ‘Digital DNA Storage Infrastructure of the Future’, involves an infrastructure that supports encoding of digital transformation in DNA, which will lead to a new form of data storage for the future.
ARTeSYN Biosolutions, the manufacturer of single-use solutions for biopharma processing, is to significantly expand its Waterford operations by adding 50 new roles in Production, Engineering, Customer Service and Research & Development over the next 3 years at its facilities in the Six Cross Roads Business Park, Waterford.
The founder of an Ireland South East-based healthcare company that develops pharmaceutical cancer treatments for children and women has been named Ireland’s Best Young Entrepreneur for 2019.
Swedencare AB, which acquired the Nutri-Science brand, product range and manufacturing facility in Waterford, Ireland South East in November 2016, announced today it has moved into new, larger premises, which was purchased earlier this year, in the city which it has redeveloped to more than double its capacity and secure and expand its workforce presence in Waterford. Read more
The Tánaiste and Minister for Foreign Affairs and Trade Simon Coveney paid a visit to Teva Waterford recently. Read more
An Taoiseach Leo Varadkar TD, Minister for Business, Enterprise and Innovation Heather Humphreys TD and IDA Ireland today welcomed the announcement that MSD is to construct a second manufacturing facility at its existing site in Carlow with the creation of 170 new jobs. Read more
Eurofins BioPharma Product Testing Ireland, Ltd. today opened the new extension to its laboratory facility in Dungarvan, Co Waterford. Read more
The new 13,000 square metre facility, first announced last October, will be constructed on a site adjacent to MSD’s existing Carlow plant in Ireland South East and will focus on the production of vaccines and biologics. Read more
